FindTrial
Sign In

Comparative study of Hingwadi Churna and Rajah Pravartani Vati in Kashtartava

Comparative clinical evaluation of Hingwadi Churna with Rajah-Pravartani-Vati in the management of Kashtartava with special reference to Primary Dysmenorrhoea. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106823
Enrollment
60
Registered
2026-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N818- Other female genital prolapse

Interventions

None listed

Sponsors

Chandra Shekhar Singh Ayurved Chikitsalaya evam Shodh Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants coming with chief complaint of Kashtartava with scanty or average amount of menses Participants suffering with Kashtartava for more than 2 consecutive cycles

Exclusion criteria

Exclusion criteria: Participants suffering from secondary dysmenorrhea ,STIs, systemic diseases, Participants having organic pathology of uterus and adnexa e.g. Fibroid uterus, carcinoma of endometrium etc, Participants having Dysfunctional Uterine Bleeding, Participants with H/O Thyroid dysfunction.

Design outcomes

Primary

MeasureTime frame
Pain intensity assessed by Visual Analog Scale (VAS) during menstruationTimepoint: 3 months—

Secondary

MeasureTime frame
Duration of menstrual pain (in hours) during each cycle Assessment of associated symptoms such as nausea, vomiting, fatigue, and headache Requirement of rescue medication (if any) Improvement in quality of life during menstruationTimepoint: 90 days—

Countries

India

Contacts

Public ContactPROF DR MAYANK KESHARWANEE

Chandra Shekhar Singh Ayurvedic Sansthan

jayachaudhary20061993@gmail.com6306251439

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026